Cholangiocarcinoma is a lethal malignancy of the biliary epithelium that can arise anywhere
along the biliary tract. Surgical resection confers the greatest likelihood of long‐term …

Biliary tract cancers (BTC) are a disease entity comprising diverse epithelial tumors, which
are categorized according to their anatomical location as intrahepatic (iCCA), perihilar …

To evaluate the safety and efficacy of carbon-ion radiotherapy (CIRT) for
cholangiocarcinoma via a multicenter retrospective study. Clinical data were collected from …

Background Biliary tract cancers (BTC) are rare and aggressive malignancies originating
from intrahepatic and extrahepatic bile ducts and the gallbladder. Surgery is the only …

Objective: To investigate the clinical outcomes and failure patterns of patients with
unresectable cholangiocarcinoma (CC) who had been treated with proton beam therapy …

Background Although surgical resection is the preferred curative-intent treatment option for
patients with non-metastatic, extra-hepatic biliary cancer (EBC), radiotherapy (RT) or …

Radiotherapy (RT) is a treatment option for advanced biliary tract cancer (BTC), often
combined with sequential and/or concurrent chemotherapy. The use of modern RT …

Introduction Biliary tract cancers (BTC) are rare and aggressive neoplasms. The current
management of locally advanced or unresectable BTC is primarily based on chemotherapy …

This study aimed to compare the dose distributions and clarify the dosimetric characteristics
of spot-scanning proton therapy (SSPT) and photon volumetric modulated arc therapy …

Purpose The role of stereotactic ablative radiotherapy (SABR) in patients with unresectable
or medically inoperable cholangiocarcinoma remains unclear. We examined the efficacy …